Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jiong Yan

Showing results (91-100 of 96) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 96 results.
American Journal of Hematology|July 22, 2014
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group studyRobert Paul Hasserjian, Federico Campigotto, Veronica Klepeis, et al.
Nature Genetics|January 19, 2002
Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasiaCornelius F Boerkoel, Hiroshi Takashima, Joy John, et al.
Oncotarget|August 25, 2016
Therapeutic relevance of the protein phosphatase 2A in cancerChelsea E Cunningham, Shuangshuang Li, Frederick S Vizeacoumar, et al.
American Journal of Human Genetics|March 16, 2007
Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral refluxWeining Lu, Albertien M van Eerde, Xueping Fan, et al.
BMC Ophthalmology|May 8, 2016
Worldwide Argus II implantation: recommendations to optimize patient outcomesDevon H Ghodasra, Adrienne Chen, J Fernando Arevalo, et al.
American Journal of Ophthalmology|June 26, 2018
Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International StudyNinel Z Gregori, Natalia F Callaway, Catherine Hoeppner, et al.
Pageof 10

Showing results (91-100 of 96) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 96 results.
American Journal of Hematology|July 22, 2014
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group studyRobert Paul Hasserjian, Federico Campigotto, Veronica Klepeis, et al.
Nature Genetics|January 19, 2002
Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasiaCornelius F Boerkoel, Hiroshi Takashima, Joy John, et al.
Oncotarget|August 25, 2016
Therapeutic relevance of the protein phosphatase 2A in cancerChelsea E Cunningham, Shuangshuang Li, Frederick S Vizeacoumar, et al.
American Journal of Human Genetics|March 16, 2007
Disruption of ROBO2 is associated with urinary tract anomalies and confers risk of vesicoureteral refluxWeining Lu, Albertien M van Eerde, Xueping Fan, et al.
BMC Ophthalmology|May 8, 2016
Worldwide Argus II implantation: recommendations to optimize patient outcomesDevon H Ghodasra, Adrienne Chen, J Fernando Arevalo, et al.
American Journal of Ophthalmology|June 26, 2018
Retinal Anatomy and Electrode Array Position in Retinitis Pigmentosa Patients After Argus II Implantation: An International StudyNinel Z Gregori, Natalia F Callaway, Catherine Hoeppner, et al.
Pageof 10